As part of its global expansion strategy, Vivimed Labs has incorporated three overseas subsidiaries. The company has floated its arm in Mauritius, UK and Spain.
Earlier in June, the company entered into an FCCB subscription agreement with International Finance Corporation (IFC), a World Bank Group, wherein IFC will subscribe to the company’s FCCB’s, on private placement basis to the tune of $7.5 million.
The company is engaged in the business of manufacturing ingredients for the home and personal care (H&PC) industry and Contract Research and Manufacturing Services (CRAMS). It carries on its business from 4 manufacturing facilities which are located at Bidar (Karnataka), Jeedimetla (Hyderabad), Bonthapally (Hyderabad) and Kashipur (Uttaranchal).
